Amsterdam, 21 July 2022 – Our portfolio company Mauritskliniek intends to join Corius. Mauritskliniek provides healthcare services in dermatology, varicose veins, proctology, skin therapy and medical-cosmetic care. The Mauritskliniek is located in Amsterdam, The Hague, Nijmegen, Utrecht and Veldhoven. Corius is the largest network of dermatology and phlebology practices in Germany and Switzerland.
By acquiring Mauritskliniek, Corius geographically expands its European healthcare offerings to the Netherlands. Both the services and vision of Mauritskliniek are perfectly consistent with those of Corius.
Mauritskliniek intends to join Corius in the third quarter of 2022, after potential approval of the Nederlandse Zorgautoriteit (NZa).
About Corius
Corius is a network of dermatology and phlebology practices. Doctors and partners of Corius deliver the highest level of quality and apply the most modern technology. An absolute passion for the job and patients is pivotal in the way of working. Corius offers their patients holistic and individual treatments, whereby in-house expert knowledge is shared across cross-clinics and colleagues. Employees follow additional education and trainings throughout. Corius has 32 practices and employs 139 doctors and 615 employees. About 450.000 patients are treated each year. www.corius.de
About Mauritskliniek
Mauritskliniek is a specialized clinic for dermatology, treatment for varicose veins and medical-cosmetic care. After the acquisition of Kliniek Veldhoven in 2020, the range of cosmetic-care has been further expanded. The clinics are known for high quality and a pleasant way of working. Their values are personal, clear and well organized. The clinics offer both insured and uninsured care. Customer satisfaction is rated with 8.6/10 points, according zorgkaartnederland.nl. www.maurtiskliniek.nl
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.
Supply Chain Company opens offices in Spain and UK
Supply Chain Company opens offices in Spain and UKRising demand for planning solutions drives international growth of Dutch IT service provider The Dutch IT service provider Supply Chain Company continues to expand. It opened an office in Spain earlier this year, and...
Holland Capital Invests in Curess
Holland Capital Invests in Curess Amsterdam, June 20th, 2024 – Holland Capital participates in Curess, a leading organization in youth care focused on systemic family support. Through the collaboration with Holland Capital, further growth and development can be...
LMtec Digital Solutions completes rebranding to Emixa
LMtec Digital Solutions completes rebranding to Emixa Naarden, June 10th, 2024 – Our portfolio company Emixa, the leading SAP/Siemens/Mendix technology partner, is finalizing the latest phase of its rebranding to one brand. The most recent acquisition LMtec Digital...
Holland Capital invests in Hybrid Power Units & Top Systems
Holland Capital invests in Hybrid Power Units & Top Systems Amsterdam/Stadskanaal/Bodegraven, April 22, 2024 – Holland Capital invests in Hybrid Power Units ('HPU') and Top Systems ('TS'), both companies supply battery-based energy solutions. Holland...
The YOEP group joins forces with PHHaastrecht
The YOEP group joins forces with PHHaastrecht Amsterdam, April 15, 2024 – Our participation the YOEP group will continue together with PHHaastrecht. By joining forces, made possible by Holland Capital, the YOEP group strengthens its youth and adult mental...
Da Vinci Laboratory Solutions accelerates growth through acquisition of JSB
Da Vinci Laboratory Solutions accelerates growth through acquisition of JSB Amsterdam, April 10, 2024 –Our portfolio company Da Vinci Laboratory Solutions (Da Vinci) is acquiring industry peer JSB. Da Vinci and JSB are two well-established companies in the...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11
Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01





